Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 2, 1998, Pages 157-167

  Luoma, Jukka S ^a   Strålin, Pontus ^b   Marklund, Stefan L ^b   Hiltunen, Timo P ^c   Särkioja, Terttu ^d   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

Inducible nitric oxide snythase; Macrophages; Oxidized LDL; Peroxynitrine; SOD

Indexed keywords

EPITOPE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXYNITRITE; PROTEIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE;

EID: 0031863285     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.2.157     Document Type: Article

References (30)

1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
2. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak. Anterioscler Thromb Vasc Biol. 1996;16:831-842.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (Lond). 1993;362:801-809.
4. Ylä-Herttuala S. Role of lipid and lipoprotein oxidation in the pathogenesis of atherosclerosis. Drugs Today. 1994;30:507-514.
5. Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;10:709-720.
6. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 1995;92: 898-903.
7. Sharma RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries. Arterioscler Thromb. 1992;12:403-415.
8. Strålin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol. 1995;15:2032-2036.
9. Sherman L, Dafni N, Lieman-Hurwitz J, Groner Y. Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA. Proc Natl Acad Sci USA. 1983;18:5465-5469.
10. Beck Y, Oren R, Amit B, Levanon A, Gorecki M, Hartman JR. Human Mn superoxide dismutase cDNA sequence. Nucleic Acids Res. 1987; 15:9076.
11. Hjalmarsson K, Marklund SL, Engström Å, Edlund T. Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc Natl Acad Sci U S A. 1987;84:6340-6344.
12. Karlsson K, Marklund SL. Extracellular superoxide dismutase in the vascular system of mammals. Biochem J. 1988;255:223-228.
13. Karlsson K, Sandström J, Edlund A, Marklund SL. Turnover of extracellular-superoxide dismutase in tissues. Lab Invest. 1994;70: 705-710.
14. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
15. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biologic messenger. Cell. 1992;70:705-707.
16. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319-1330.
17. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R. The participation of nitric oxide in cell-free- and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim Biophys Acta. 1992;1180: 73-82.
18. Yates MT, Lambert LE, Whitten PJ, McDonald I, Mano M, Ku G, Mao SJT. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett. 1992;309: 135-138.
19. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis. FEBS Lett. 1993;334:170-174.
20. Malo-Ranta U, Ylä-Herttuala S, Metsä-Ketelä T, Jaakkola O, Moilanen E, Vuorinen P, Nikkari T. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low-density lipoprotein. FEBS Lett. 1994;337: 179-183.
21. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalyaranaraman D, Freeman B. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys. 1995;324:15-25.
22. Radi R, Beckman JW, Bush KM, Freeman BA. Peroxynitrite induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
23. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993; 9:371-377.
24. Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
25. Albina J. On the expression of nitric oxide synthase by human macrophages: why no NO? J Leukoc Biol. 1995;58:643-649.
26. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA. 1990; 87:6959-6963.
27. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Särkioja T, Witztum JL, Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid protein adducts. J Clin Invest. 1991;87:1146-1152.
28. 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest. 1994;93:2014-2021.
29. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation. 1995;92:1355-1374.
30. Hiltunen TP, Nikkari T, Ylä-Herttuala S. O. cuniculus mRNA for extracellular superoxide dismutase. EMBL Data Library. Accession No. X78139. European Bioinformatics Institute, Hinxton Genome Campus, Cambridge CB10 1RQ, England datalib@ebi.ac.uk